Hos hypertensive diabetespatienter med mikroalbuminuri og normal nyrefunktion forekom hyperkaliæmi (≥ 5, 5 mEq/ l) hos 29, 4% (dvs. meget almindelig) af patienterne i 300 mg irbesartan- gruppen og hos 22% af patienterne i placebo- gruppen.
In diabetic hypertensive patients with microalbuminuria and normal renal function, hyperkalaemia (≥ 5.5 mEq/ L) occurred in 29.4% (i. e. very common) of the patients in the irbesartan 300 mg group and 22% of the patients in the placebo group.